Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @agexthera
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @agexthera
-
Prikvačeni tweet
AgeX and our founder & CEO
@DrMichaelWest are included in this cover story Special Report from New Scientist magazine: "A Cure for Ageing" Available on newsstands now, worldwide.$AGE#Longevity@newscientist@AubreydeGreyhttps://www.newscientist.com/article/mg24232270-100-anti-ageing-drugs-are-coming-that-could-keep-you-healthier-for-longer/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@BioWorld covers AgeX and its Collaboration with Japanese Biopharma Company to Generate Hypoimmunogenic Cells (Subscription paywall)$AGEhttps://www.bioworld.com/articles/432711-cell-therapy-firm-agex-looks-west-to-expand-into-japan?v=preview …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics proslijedio/la je Tweet
Cell therapy firm Agex looks west to expand into Japanhttps://www.bioworld.com/articles/432711-cell-therapy-firm-agex-looks-west-to-expand-into-japan …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX's VP of New Tech Disc
@aubreydegrey is on a panel on the new book by@chipwalter tomorrow (Thur 1/30)@cwclub. Other panelists are Walter, Cynthia Kenyon@calico, &@HaririRobert@celularity Moderated by@BBCNews contributor@FreshDialogues$AGE http://bit.ly/37xHqH1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics proslijedio/la je Tweet
#AgeX collaborates with#Japanese#biopharma@agexthera announces a#research collaboration with an as-yet-undisclosed#biopharm co. to further development of its#immunotolerance techn platform.#longevity#pharma#drugdevelopment https://bit.ly/3aT5HJO@gbpalantir@AsklepianCpic.twitter.com/bVwSBYVsmS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2/2 > Secures milestone collaboration in
#Japan, where#celltherapy R&D is advancing rapidly in a favourable regulatory and commercial environment > UniverCyte platform has potential to deliver cells as therapeutics that do not require immunosuppressive therapyPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1/2 AgeX Therapeutics Enters Research Collaboration w/ Japanese Biopharma Company to Generate Hypoimmunogenic Cells > 1st collaboration for UniverCyte technology platform, marking launch of new business development and collaboration strategyhttps://www.businesswire.com/news/home/20200129005279/en/AgeX-Therapeutics-Enters-Research-Collaboration-Japanese-Biopharma …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics Presenting at Four Conferences this month: >
#BiotechShowcase, Jan 13-15 during#JPM20 > PMWC 2020#PMWC20 Jan 21-24 > World Stem Cell Summit Jan 21-24 >#Longevity Therapeutics Jan 28-30$AGE@PMWCintl@WSCSummithttps://www.businesswire.com/news/home/20200114005342/en/AgeX-Therapeutics-Participate-Conferences-January-2020 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics proslijedio/la je Tweet
Innovation for Age-related Disease Treatments
@agexthera. Listen to@DrMichaelWest here: http://bit.ly/30vhtVP Subscribe and review our Podcast on iTunes: http://apple.co/2ObykIO#humanagingpic.twitter.com/RTIzG7mTyI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Watch a video of AgeX's founder & CEO Dr. Michael West explaining the significance of the new patent related to iPSCs
$AGE#stemcells#longevity#regenerativemedicine#iPSCshttps://vimeo.com/378442290Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The New patent, No. 10,501,723, has an early priority date, having been filed before the first scientific publication of Shinya Yamanaka on iPSCs, for which he won the
#NobelPrize for Physiology or Medicine in 2012.$AGE#stemcells#longevity#regmed#celltherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics & Lineage Cell Therapeutics Announce Issuance of US Patent for Method of Generating Induced Pluripotent Stem Cells (
#iPSCs)$AGE$LCTX#stemcells#celltherapy#longevity@LineageCellhttps://www.businesswire.com/news/home/20191210005435/en/AgeX-Therapeutics-Lineage-Cell-Therapeutics-Announce-Issuance …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics Issues Year-End Letter to Shareholders
$AGEhttp://bit.ly/2qBypg1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics to Present at Metabesity 2019 October 15-16 in Washington, DC
$AGE@Metabesity#Metabesity2019#Longevityhttps://www.businesswire.com/news/home/20191011005118/en/AgeX-Therapeutics-Present-Metabesity-2019 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics Presents at the Rodman & Renshaw / HC Wainwright Global Investment Conference
$AGEX#Longevity@HCWCO#HCWCOhttps://bwnews.pr/2k3C7vsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2/2 > Begins work using
#syntheticbiology to engineer pluripotent#stemcells w/ immune tolerance UniverCyte tech to generate hypoimmunogenic (universal) cells. > CEO@DrMichaelWest featured in cover story Special Report in@NewScientist magazine, “A Cure for Aging?”Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
1/2 AgeX Reports Q2 2019 Financial Results & Provides Business Update Highlights include: > Moves into new R&D facility: ≈15,700 sf, inc cGMP-capable manufacturing suite > Strengthens BOD w/ appt of Dr. Michael H. May, CEO of
@CCRM_ca https://bwnews.pr/2Z83R0u (cont)Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Regenerative Medicine Leader Dr. Michael H. May Joins AgeX Board of Directors > Serves at President & CEO of Canada’s Centre for Commercialization of Regenerative Medicine (CCRM)
@CCRM_ca$AGEhttps://bwnews.pr/2YExp5KHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics’ CEO
@DrMichaelWest to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Research, July 11-12 in NYC$AGE@LifespanIOhttps://www.businesswire.com/news/home/20190709005317/en/AgeX-Therapeutics%E2%80%99-CEO-Dr.-Michael-D.-West …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
$AGE http://bit.ly/2LHQqTyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health & Foresight Institute Wednesday, May 1, San Francisco
$AGE@foresightinst@DrMichaelWest@aubreydegreyhttp://bit.ly/2GRUuLvHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.